Low ferritin: why iron stores run down

Why ferritin reads iron stores better than serum iron

Many people are told their iron is normal when in fact only their circulating serum iron was measured. Ferritin is a different marker: it reflects iron held in reserve in the liver, spleen, and bone marrow — the stores the body draws on when dietary iron temporarily falls short and what sustains hemoglobin production during periods of increased demand. A comprehensive 2024 review in Blood Reviews confirmed that ferritin is the most clinically reliable indicator of absolute iron deficiency, distinguishing it from serum iron (which fluctuates throughout the day) and hemoglobin (which falls only after stores are substantially depleted). Ferritin reflects stored reserves, not circulating iron — understanding this distinction explains why depletion can be symptomatic while a standard CBC appears normal. Because ferritin is an acute-phase reactant, TSAT and hs-CRP are required context for interpreting a ferritin result — inflammation raises ferritin independently of stores, which can mask true deficiency.

Factors that deplete iron stores in the first place

Insufficient dietary iron intake (Evidence: Strong)

Dietary iron deficiency is the most common global cause of low ferritin. Individuals following plant-based diets are at higher risk because non-heme iron is absorbed at approximately 2–10%, compared with 15–35% for heme iron from animal sources. Phytates in grains and legumes, polyphenols in tea and coffee, and calcium all inhibit non-heme iron absorption; vitamin C consumed alongside iron-containing meals enhances it. Meat-eaters can also develop deficiency if overall dietary iron is insufficient relative to their requirements, which vary by age, sex, body size, and physiological state.

Menstrual blood loss (Evidence: Strong)

Heavy or prolonged menstrual periods are the leading cause of iron deficiency in premenopausal women. Monthly iron loss through menstruation can exceed dietary replacement capacity, gradually depleting stores over months to years. This pattern is clinically important: hemoglobin often remains technically within the reference range while ferritin has been slowly falling, meaning a low ferritin in a premenopausal woman should prompt evaluation of menstrual blood loss alongside dietary intake before attributing deficiency to diet alone.

Malabsorption (celiac disease, H. pylori, post-bariatric surgery) (Evidence: Moderate)

Several gastrointestinal conditions impair iron absorption. Celiac disease damages the duodenal villi where most iron absorption occurs, and iron deficiency is frequently the presenting feature before gastrointestinal symptoms become obvious. Helicobacter pylori infection, inflammatory bowel disease, and gastric bypass surgery (which bypasses the duodenum) all reduce absorptive capacity. Achlorhydria and long-term proton pump inhibitor use reduce the acidic environment necessary to convert dietary iron to the absorbable ferrous form. In individuals with persistent low ferritin despite adequate dietary intake and supplementation, malabsorption should be considered and evaluated by a provider.

High physiological iron demand (endurance training, pregnancy) (Evidence: Moderate)

Endurance athletes have elevated iron requirements due to increased red cell turnover, sweat losses, foot-strike hemolysis, and exercise-induced hepcidin release that transiently reduces iron absorption post-exercise. Pregnancy dramatically increases iron requirements, as does growth during childhood and adolescence — physiological states where iron demand can exceed what typical dietary intake provides, making ferritin monitoring particularly relevant.

Occult blood loss (GI tract) (Evidence: Strong)

Occult gastrointestinal blood loss is the most important cause to identify in men and postmenopausal women with low ferritin who are not obvious candidates for iron deficiency on dietary grounds. Sources include gastric or duodenal ulcers, colorectal polyps, inflammatory bowel disease, NSAID use, and in rare cases malignancy. Fecal occult blood testing is the appropriate screen; ferritin alone does not identify the source. Low ferritin in a man or postmenopausal woman without a clear dietary or absorptive explanation warrants gastrointestinal investigation by a provider.

Evidence-graded approaches to rebuilding iron stores

Step 1: Dietary iron optimization and absorption enhancement (Evidence: Strong for heme iron; Moderate for non-heme optimization)

Dietary approaches center on increasing heme iron consumption (red meat, poultry, fish), enhancing non-heme iron absorption through vitamin C co-consumption, and reducing absorption inhibitors at iron-containing meals. This approach is appropriate as a primary strategy in mild deficiency with a primarily dietary cause — typically ferritin in the 15–30 ng/mL range with adequate absorptive capacity. It is generally insufficient as a sole strategy in moderate to severe deficiency. Many clinicians consider ferritin below 30 ng/mL as warranting attention in symptomatic individuals, and some evidence supports targeting ferritin above 50 ng/mL for optimal resolution of fatigue-related symptoms. Retest ferritin at 8–12 weeks to confirm a dietary response.

Step 2: Oral iron supplementation under provider guidance (Evidence: Strong)

Oral iron supplements are the first-line clinical approach when ferritin is below 30 ng/mL and TSAT is below 20%, provided absorption is adequate. Ferrous sulfate is the most commonly used form due to its efficacy and low cost, though gastrointestinal side effects are common at standard doses. Ferrous bisglycinate is better tolerated in many people and shows comparable absorption in some studies. A practically important consideration: every-other-day dosing has RCT evidence supporting it as equally effective with better GI tolerance, because daily dosing triggers hepcidin release that reduces absorption of the next day's dose. Dose, form, and schedule are clinical decisions made by a provider based on severity and individual factors. Retest ferritin and hemoglobin at 8–12 weeks.

Step 3: Intravenous iron repletion where oral fails or is not tolerated (Evidence: Strong)

Intravenous iron is used when oral supplementation has been ineffective after three or more months, when absorption is severely impaired, or when clinically urgent repletion is needed — such as before surgery or in significant symptomatic anemia. Several formulations are available. This is a clinical decision made by a provider based on specific criteria; it is not a self-directed intervention. Retest ferritin at 4–6 weeks following infusion.

Step 4: Address and resolve the underlying cause of depletion (Evidence: Strong)

Iron repletion without identifying and addressing the cause of depletion will result in recurrence. Concurrent management of heavy menstrual bleeding, diagnosis and treatment of celiac disease or other malabsorptive conditions, and investigation of occult blood loss are necessary steps alongside supplementation to achieve durable recovery of iron stores. Retest ferritin at 3–6 months after the source has been addressed to confirm sustained repletion.

Anti-patterns when supplementing iron for low ferritin

Supplementing iron without first testing ferritin, TSAT, and hs-CRP

Iron supplementation when stores are already adequate is not beneficial and can worsen oxidative stress. Ferritin should confirm deficiency is present; TSAT below 20% helps confirm functional depletion; and hs-CRP should confirm the ferritin result is not inflated by active inflammation before supplementation begins.

Mega-dosing iron daily instead of every other day

Oral iron taken daily triggers hepcidin release that reduces absorption of the next day's dose. RCT evidence supports alternate-day dosing as equally effective with better gastrointestinal tolerance. Taking larger daily doses does not compensate for this mechanism and increases the likelihood of side effects that lead to discontinuation.

Supplementing iron without investigating the source of loss

Repletion without identifying and resolving the cause of depletion — whether menstrual blood loss, GI bleeding, or malabsorption — produces a temporary increase that recurs when supplementation stops. Supplementation and source investigation must proceed in parallel, not sequentially.

Interpreting a ferritin result without checking hs-CRP

Ferritin is an acute-phase reactant. Inflammation elevates ferritin independently of iron stores. A ferritin of 40 ng/mL with an hs-CRP of 15 mg/L may mask true deficiency. Always pair ferritin with hs-CRP for accurate interpretation — a ferritin result without inflammatory context is incomplete.

Routine vs urgent follow-up on low ferritin

Most low ferritin findings in otherwise healthy individuals represent a self-monitored nutritional deficiency addressable through dietary adjustment and, where indicated, oral supplementation under provider guidance. However, certain presentations move beyond this tier and require prompt clinical evaluation: hemoglobin significantly below the reference range with symptoms present at rest (indicating iron deficiency anemia requiring clinical management rather than self-directed repletion); failure to respond to three months of adequate oral supplementation (which may indicate occult GI blood loss or an absorptive failure requiring investigation); and ferritin below 12 ng/mL in a man or postmenopausal woman without a clear dietary explanation (which warrants GI evaluation for occult blood loss regardless of hemoglobin). The named clinical pathways are gastroenterology for occult GI blood loss evaluation and primary care for IV iron consideration.

Day 0 and a paced retest window for ferritin

At baseline (Day 0), draw ferritin alongside total iron, TIBC, iron saturation (TSAT), and hs-CRP to establish a complete picture before any intervention begins. Hemoglobin, if below the reference range, tends to recover faster than ferritin — typically within 2–4 weeks — because the body prioritizes hemoglobin production once iron becomes available. Ferritin stores take longer: stores begin rising within 4–6 weeks of repletion but commonly require 3–6 months to fully replenish from significantly depleted levels.

Retest cadence: ferritin and the companion panel at 8–12 weeks as a first checkpoint, then every 3 months until replete, then every 6–12 months for maintenance monitoring. Standardized conditions matter: fasted, same laboratory, same time of day. Always include hs-CRP at each draw — an elevated hs-CRP at the time of testing can artificially raise ferritin and obscure whether stores are genuinely recovering.

Companion tests for this retest panel:

• Ferritin — Primary biomarker; reference ranges and the inflammation-interference context
• Total iron — Circulating serum iron; confirms availability in the context of depleted stores
• TIBC — Rises in iron deficiency as transferrin production increases; the directional partner to ferritin
• Iron saturation (TSAT) — Distinguishes true deficiency (<20%) from inflammation-elevated ferritin masking deficiency
• hs-CRP — Required to interpret ferritin accurately when inflammation may be present

When low ferritin warrants a GI or gynecology workup

Low ferritin in a premenopausal woman should prompt evaluation of menstrual blood loss alongside dietary intake before attributing deficiency to diet alone. When heavy or prolonged menstrual bleeding is identified as the primary driver, a gynecology referral is appropriate to evaluate and manage the underlying cause — repletion alone will not produce durable results if monthly losses continue to exceed replacement capacity.

In a man or postmenopausal woman, low ferritin without a clear dietary or absorptive explanation warrants gastroenterology evaluation for occult GI blood loss. This applies even when hemoglobin remains within the reference range: ferritin below 12 ng/mL in these populations should not be attributed to diet without first ruling out a GI source. Fecal occult blood testing is the appropriate initial screen; colonoscopy may follow depending on findings and clinical risk.

Persistent low ferritin despite three or more months of adequate oral supplementation — in any population — is a signal that the source of loss has not been identified or that absorption is impaired. Either scenario warrants provider-directed investigation rather than continued empirical supplementation. At Superpower, our approach to biomarker testing is grounded in the principle that data should drive decisions — learn more at our manifesto. For unexplained low ferritin in a man or postmenopausal woman, the appropriate next step is gastroenterology evaluation for occult blood loss; for confirmed deficiency requiring rapid repletion, primary care can evaluate whether IV iron is indicated.